Krzysztof Kucharczyk graduated from Technical Physics in 1984. He prepared his master's thesis, concerning the replication of bacteriophage lambda, under the direction of Prof. Karol Taylor from the University of Gdańsk. He received his doctorate, for investigation of influence of thermal shock on the membranes of Escherichia coli bacteria, at the University of Gdańsk in 1992 under the supervision of Prof. Alina Taylor.
The same year he established the family company "Electrophoretic Techniques" the head of which he is to the present day. The company develops, manufactures and sells products for nucleic acid and protein analysis both in Poland and in the EU. The first patent granted to the company by the U.S. Patent Office included the invention of increasing the spatial diversity of nucleic acids conformations by application of step changes of temperature during native electrophoresis. Both the author of this invention and the USPTO did not specify the mechanism of this phenomenon, but the patent was granted and, thanks to its use, two different variants of the influenza virus were detected in humans, among others: drug-resistant, minority genetic variants in solid tumours and for the first time worldwide. In cooperation with national and foreign scientific units, the company participated in the development of the most accurate (at the time of publication) test for estimating human age based on blood samples, recombinant viral vaccines and antiviral DNA vaccines for poultry. The company is also involved in projects to discover new drugs for the treatment of autoimmune and cancer diseases. Returning to its roots, the company is involved in a project to build an automated ion spectrometer of volatile substances.